← Leaderboards
Govindarajan Rajagopalan
Mayo Clinic Rochester
$1,888,879
Attributed
$2,473,204
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $560.5K · FY2012–20$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,473,204 · 3
By mechanism
R01$1,587,254 · 1
R21$885,950 · 2
Top collaborators
- Chella S David3 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Vaidehi Radhakrishna Chowdhary$642,250
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoProductionInfectionExotoxinsImmune ResponseHla-Dr3 AntigenToxinResponseSuperantigensT-LymphocyteBiologicalMouse ModelPlayTransgenic MiceStaphylococcus AureusVirulenceMolecularPneumoniaMediatingT-Cell ActivationCellsResistancePathogenicityPathogenesis
Grant awards (9)
Exploring the role of staphylococcal superantigens in immune evasion and persistence of Staphylococcus aureus biofilms using humanized mouse models$209,375
R21 · FY2020 · AI · contact PI
Exploring the role of staphylococcal superantigens in immune evasion and persistence of Staphylococcus aureus biofilms using humanized mouse models$251,250
R21 · FY2019 · AI · contact PI
HLA class II transgenic mouse models for S. aureus infections and superantigens$306,711
R01 · FY2016 · AI · contact PI
HLA class II transgenic mouse models for S. aureus infections and superantigens$111,893
R01 · FY2016 · AI · contact PI
HLA class II transgenic mouse models for S. aureus infections and superantigens$397,500
R01 · FY2015 · AI
HLA class II transgenic mouse models for S. aureus infections and superantigens$397,500
R01 · FY2014 · AI
HLA class II transgenic mouse models for S. aureus infections and superantigens$373,650
R01 · FY2013 · AI
Novel Combination Therapy for Staphylococcus aureus Pneumonia$186,825
R21 · FY2013 · AI · contact PI
Novel Combination Therapy for Staphylococcus aureus Pneumonia$238,500
R21 · FY2012 · AI · contact PI